Logo
Home Study Material Contact Search
AI Chat FREE
  1. business
  2. accounting
  3. exercise 18-7 flounder biotech enters into a licen

Exercise 18-7 Flounder Biotech enters into a licensing agreement with Pang Pharmaceutical for a drug...

70.2K

Verified Solution

Question

Accounting

image
Exercise 18-7 Flounder Biotech enters into a licensing agreement with Pang Pharmaceutical for a drug under development. Flounder will receive a payment of $7,700,000 if the drug receives regulatory approval. Based on prior experience in the drug-approval process, Flounder determines it is 80% likely that the drug will gain approval and a 20% chance of denial. Determine the transaction price of the arrangement for Flounder Biotech. Transaction price SHOW LIST OF ACCOUNTS Assuming that regulatory approval was granted on December 20, 2017, and that Flounder received the payment from Pang on January 15, 2018, prepare the journal entries for Flounder. The license meets the criteria for point-in-time revenue recognition. (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No entry" for the account titles and enter 0 for the amounts.) Date Account Titles and Explanation Debit Credit

Answer & Explanation Solved by verified expert
Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:
  • Unlimited Question Access with detailed Answers
  • Zin AI - 3 Million Words
  • 10 Dall-E 3 Images
  • 20 Plot Generations
  • Conversation with Dialogue Memory
  • No Ads, Ever!
  • Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
Become a Member

Other questions asked by students